CHI’s 2nd Annual Preclinical Development
Venue: San Francisco,
|Event Date/Time: Feb 22, 2006||End Date/Time: Feb 24, 2006|
Numerous opportunities exist to implement innovative paradigms to optimize candidate progression from discovery to early clinical evaluation. Successful development of new translational biomarkers will enable the progression of candidates from preclinical to clinical, and provide a means of predicting success in humans.
Who should attend: Scientists, Senior Scientists, Heads, Directors, Senior Directors, Vice Presidents, Senior Vice Presidents, of Preclinical R&D, Preclinical Studies, Preclinical & Regulatory Affairs, Preclinical Discovery, Preclinical Laboratory, Preclinical Development, Preclinical Sciences, Preclinical Pharmacology & Toxicology, Preclinical Biostatistics, Preclinical Models, Preclinical Biology, and Preclinical Safety